Latest Breaking News On - Multi cytokine inhibition - Page 1 : comparemela.com

Equillium Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced a presentation at the 18th.

United statesSan diegoAdrianj giovannoneTranslational science early development at equilliumEquillium incOno pharmaceutical co ltdScripps seaside forumAnnual peptide therapeutics symposiumPeptide staplingBetter stabilityLoral deliveryAssociate directorTranslational scienceEarly developmentCeliac diseaseMulti cytokine inhibition